Request for Free Sample

Table Of Contents:

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Component

  2.3.2 Market Size By Deployment Mode

  2.3.3 Market Size By Technology

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Regulatory & Compliance Automation Metrics

  4.1.1 Case Reporting Compliance Rate: Accuracy and timeliness of regulatory submissions (FDA, EMA, MHRA)

  4.1.2 Audit Trail Completeness: Extent of traceability in automated safety systems

  4.1.3 Submission Cycle Efficiency: Reduction in regulatory reporting timelines

  4.1.4 Global Compliance Coverage: Ability to support multi-region regulatory frameworks

  4.1.5 Rule-Based Validation Coverage: Automation of compliance checks in safety databases

4.2 Case Processing & Workflow Automation Metrics

  4.2.1 Case Intake Automation Rate: Share of adverse event cases processed automatically

  4.2.2 Case Processing Time Reduction: Efficiency improvement in end-to-end case handling

  4.2.3 Data Entry Automation Level: Reduction in manual input for safety case creation

  4.2.4 Workflow Bottleneck Reduction: Elimination of manual review delays

  4.2.5 Case Routing Efficiency: Automated assignment of cases to safety teams

4.3 Signal Detection & Risk Management Metrics

  4.3.1 Signal Detection Sensitivity: Accuracy in identifying safety risks early

  4.3.2 False Positive Reduction Rate: Decrease in incorrect safety alerts

  4.3.3 Risk Prioritization Efficiency: Automated ranking of safety signals

  4.3.4 Aggregate Data Processing Speed: Ability to analyze large safety datasets

  4.3.5 Benefit-Risk Evaluation Automation: Use of AI models for safety assessment

4.4 AI, Analytics & Technology Integration Metrics

  4.4.1 AI Adoption in PV Systems: Use of machine learning for case processing

  4.4.2 NLP Extraction Accuracy: Precision in extracting safety data from unstructured sources

  4.4.3 Predictive Safety Modeling Usage: Forecasting of adverse event trends

  4.4.4 System Integration Level: Connectivity with EHR, clinical trials, and databases

  4.4.5 Cloud Deployment Penetration: Adoption of SaaS-based pharmacovigilance platforms.

5. Pharmacovigilance Automation Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (USD Billion)  

5.1 Introduction

 5.2 Software

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Services

6. Pharmacovigilance Automation Market Segmental Analysis & Forecast, By Deployment Mode, 2022–2035, Value (USD Billion)  

    6.1 Introduction

 6.2 Cloud-Based

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 On-Premises

 6.4 Hybrid

 6.5 Software-as-a-Service (SaaS)

7. Pharmacovigilance Automation Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)  

    7.1 Introduction

 7.2 Artificial Intelligence (AI)

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Machine Learning (ML)

 7.4 Natural Language Processing (NLP)

 7.5 Robotic Process Automation (RPA)

 7.6 Others

8. Pharmacovigilance Automation Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)  

    8.1 Introduction

 8.2 Pharmaceutical Companies

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Biotechnology Companies

 8.4 Contract Research Organizations (CROs)

 8.5 Others

9. Pharmacovigilance Automation Market Segmental Analysis & Forecast, By Region, 2022–2035, Value (USD Billion)  

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Pharmacovigilance Automation Market Size & Forecast, By Component, 2022–2035

 9.2.3 Pharmacovigilance Automation Market Size & Forecast, By Deployment Mode, 2022–2035

 9.2.4 Pharmacovigilance Automation Market Size & Forecast, By Technology, 2022–2035

 9.2.5 Pharmacovigilance Automation Market Size & Forecast, By End User, 2022–2035

 9.2.6 Pharmacovigilance Automation Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Pharmacovigilance Automation Market Size & Forecast, By Component, 2022–2035

 9.3.3 Pharmacovigilance Automation Market Size & Forecast, By Deployment Mode, 2022–2035

 9.3.4 Pharmacovigilance Automation Market Size & Forecast, By Technology, 2022–2035

 9.3.5 Pharmacovigilance Automation Market Size & Forecast, By End User, 2022–2035

 9.3.6 Pharmacovigilance Automation Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Pharmacovigilance Automation Market Size & Forecast, By Component, 2022–2035

 9.4.3 Pharmacovigilance Automation Market Size & Forecast, By Deployment Mode, 2022–2035

 9.4.4 Pharmacovigilance Automation Market Size & Forecast, By Technology, 2022–2035

 9.4.5 Pharmacovigilance Automation Market Size & Forecast, By End User, 2022–2035

 9.4.6 Pharmacovigilance Automation Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Pharmacovigilance Automation Market Size & Forecast, By Component, 2022–2035

 9.5.3 Pharmacovigilance Automation Market Size & Forecast, By Deployment Mode, 2022–2035

 9.5.4 Pharmacovigilance Automation Market Size & Forecast, By Technology, 2022–2035

 9.5.5 Pharmacovigilance Automation Market Size & Forecast, By End User, 2022–2035

 9.5.6 Pharmacovigilance Automation Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Pharmacovigilance Automation Market Size & Forecast, By Component, 2022–2035

 9.6.3 Pharmacovigilance Automation Market Size & Forecast, By Deployment Mode, 2022–2035

 9.6.4 Pharmacovigilance Automation Market Size & Forecast, By Technology, 2022–2035

 9.6.5 Pharmacovigilance Automation Market Size & Forecast, By End User, 2022–2035

 9.6.6 Pharmacovigilance Automation Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Oracle Corporation

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

 10.6.2 Veeva Systems Inc.

 10.6.3 IQVIA Holdings Inc.

 10.6.4 ArisGlobal LLC

 10.6.5 Accenture plc

 10.6.6 Cognizant Technology Solutions Corporation

 10.6.7 Tata Consultancy Services Limited

 10.6.8 Infosys Limited

 10.6.9 Wipro Limited

 10.6.10 Tech Mahindra Limited

 10.6.11 HCL Technologies Limited

 10.6.12 Genpact Limited

 10.6.13 Capgemini SE

 10.6.14 Parexel International Corporation

 10.6.15 ICON plc

 10.6.16 EVERSANA

 10.6.17 Ennov SAS

 10.6.18 AB Cube SAS

 10.6.19 RXLogix Corporation

 10.6.20 Indegene Limited

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures